INTELLECTUAL PROPERTY AND PATENTS Sample Clauses
The "Intellectual Property and Patents" clause defines the ownership, use, and protection of intellectual property (IP) and patent rights arising from or used in the course of an agreement. Typically, this clause specifies whether IP created during the relationship belongs to one party or is jointly owned, and may outline procedures for disclosing inventions, filing patent applications, or licensing existing IP. Its core function is to prevent disputes by clearly allocating rights and responsibilities regarding inventions, trademarks, copyrights, and patents between the parties.
INTELLECTUAL PROPERTY AND PATENTS. 27.1 Intellectual property consists of inventions, publications, computer software, courseware, works of art and music, data bases, lecture notes, laboratory manuals, articles, books, as well as all other creations that can be protected under patent, copyright, trademark or similar laws.
27.2 Copyright is owned by the members who create intellectual property, except in either of the following cases:
27.2.1 where there is a written contract to the contrary between the member, the Employer, and/or a third party which assigns some or all ownership rights of the intellectual property to the Employer or the third party. The member shall negotiate such an agreement with the assistance of a representative of the Faculty Association;
27.2.2 where the Employer provides funds, resources, and facilities to the member beyond those required for the payment of the member’s salary and benefits or for the provision of a normal academic environment in which to work, in which case the member shall, with the assistance of a representative of the Faculty Association, come to agreement with the Vice-President (Academic) on sharing ownership rights to the intellectual property with the Employer.
27.3 The Employer has a non-exclusive, royalty-free, irrevocable, indivisible, and non- transferable right to retain for archival purposes and to use for internal educational and research purposes only any intellectual property developed by members with the use of the Employer’s time, facilities, and resources. Such right shall not include the right to transfer, license, exploit or use the intellectual property for distance education or for any purpose other than the internal use of the University.
27.4 Members have intellectual and artistic freedom in the creation of intellectual property and the right to disseminate the intellectual property which they own. Such right shall not include the right to transfer, licence, exploit, or use intellectual property developed and/or delivered through the Department of Distance Learning and Continuing Education under the terms of Article 25 without the agreement of the Employer.
INTELLECTUAL PROPERTY AND PATENTS. (a) ▇▇▇▇▇▇ will retain and own all right, title and interest in and to any intellectual property (x) that ▇▇▇▇▇▇ owned or had rights to before the date of the order subject to these General Terms and/or (y) on Goods that result from use of Buyer’s designs, specifications or instructions. Consequently, by submitting designs, specifications or instructions to ▇▇▇▇▇▇, Buyer irrevocably agrees that ▇▇▇▇▇▇ shall be free to use the same, free of charge, and in the broadest possible manner (and not only to manufacture Goods for Buyer), for the entire period of protection afforded to intellectual property rights (including any extension thereof) which could cover Buyer’s designs, specifications or instructions. To the extent any aspects of any Goods resulting from the use of Buyer’s designs, specifications or instructions is not automatically the exclusive property of Safran, Buyer hereby irrevocably assigns to Safran, on an exclusive basis, free of charge, all right, title and interest in and to any intellectual property on any such Goods, allowing ▇▇▇▇▇▇ to use and exploit the same in any part of the world and for the entire duration of protection of said intellectual property rights, including in particular the exclusive right to exploit, reproduce, present, adapt, modify, translate, distribute, license, sell, market and use the same, in the broadest possible manner, for the entire period of protection afforded to intellectual property rights (including any extension thereof). Such assignment is made without limitation as to the number of reproductions or presentations that may be made, in all countries and in all languages, by all means of exploitation and on all current or future types of media, including computer media, multimedia, networks, including the internet, and by direct or satellite broadcasting. The sale of Goods (including if manufactured according to Buyer’s designs, specifications or instructions) or any parts thereof hereunder confers on Buyer no license under any patent or other intellectual property rights of Safran covering or relating inter alia to (i) the structure of any devices to which the Goods or parts may be applied or (ii) a process or machine in connection with which they may be used, and does not allow Buyer to create or develop derivatives works or products from the Goods thereafter.
(b) Buyer will indemnify, defend and hold Safran harmless against any losses, liabilities, damages, costs or expenses, including, without limitation...
INTELLECTUAL PROPERTY AND PATENTS. 2.5.1 Both the supervisor and student are aware that intellectual property, including data generated during postgraduate research and study, belongs to Stellenbosch University, according to the SU IP policy. Copies of all data (raw and analysed) must be submitted to the supervisor on completion of the study (General Policies and Rules: Calendar Part 1) (In case of any IP related queries please contact Innovus).
INTELLECTUAL PROPERTY AND PATENTS. (a) Intellectual Property (“IP”) means all copyright and all rights in relation to inventions (including patent rights), registered and unregistered trademarks (including service marks), registered and unregistered designs, circuit layouts, and any other rights resulting from intellectual activity in the industrial, scientific, literary and artistic fields recognised in domestic law anywhere in the world.
(b) Where IP is owned and supplied by a party (whether separately or as part of the Goods), that party shall retain ownership of all such IP. The other party undertakes not to disclose any information related to such IP to any third parties without the prior written consent of the first party, except where it is necessary for the usual or intended use of the Goods.
(c) The ownership in IP which is created under or otherwise in connection with the PO, shall vest in the party which created such IP. In case that the Purchaser is not be the owner of such IP, then the Purchaser shall be granted by the owner of such IP, a royalty-free, irrevocable, world-wide, perpetual, non-exclusive, unrestricted license regarding such IP. Said licence shall not be limited to a particular project or purpose, shall include the right to sub-license and all documentation, data, samples or any other materials developed or created in connection with such IP.
(d) Supplier warrants that Goods supplied – other than Goods supplied in accordance with technical plans or drawings provided to Supplier by Purchaser – do not infringe any IP, and shall hold harmless and indemnify Purchaser from and against all claims and proceedings for or on account of such infringements in respect of Goods supplied by Supplier and from and against all related claims, demands, proceedings, damages, costs, charges and expenses.
INTELLECTUAL PROPERTY AND PATENTS. 8.1 Patent ownership. Syngenta shall own the entire right, title, and interest in and to all Patent Rights and shall have the exclusive right to apply for, seek issuance of, and maintain or abandon any or all of Syngenta's Patent Rights.
INTELLECTUAL PROPERTY AND PATENTS. The Buyer shall hold REFRACTRON harmless against any expenses, damages, costs, or losses resulting from any suit or proceeding brought for infringement of patents, copyrights, trademarks or trade secrets or for unfair competition arising from compliance with Buyer’s designs or specifications or instructions.
INTELLECTUAL PROPERTY AND PATENTS. 2.1. The Employee undertakes to immediately bring to Teva’s attention or the attention of whoever is designated by Teva, all Confidential Information or other information, created, developed or which came to Employee’s attention and which relates to Teva’s field of operations, including any improvement, invention, innovation, process, creation, discovery, formula, technique, conclusions, knowledge, findings, research results, examination or experiment, developments, designs, ideas, etc., whether or not patentable or eligible to be protected as another proprietary right, whether or not forming the subject-matter of an application for registration of the right, whether or not it constitutes a service invention in accordance with the law, which were made, conceived, produced or implemented, developed or formed, in whole or in part, by the Employee alone or jointly with others, in Israel or abroad, during the Term of Employment at Teva or in connection with the Employee’s work at Teva (hereinafter, jointly and severally: “Information Created by the Employee”). For the avoidance of any doubt, it is hereby clarified that Information Created by the Employee will include, inter alia, information created, formed or developed after the commencement of the Term of Employment (even if conceived or developed prior to the execution of this Letter of Undertaking) and/or after termination thereof, provided that the information relates, directly or indirectly, to the Employee’s work and/or employment with Teva
2.2. The Employee hereby represents and confirms that all the rights in and to the Information Created by the Employee, including, without derogating from the generality of the foregoing, in service inventions, as such term is defined in the Patents Law, 5727-1967 (the “Patents Law”), as may be amended from time to time, and in anything relating thereto, are, as of the time of their creation, the sole property of Teva, and that the Employee does not and will not have any rights, demands, or claims in connection with the proprietary rights and/or other rights of any kind whatsoever, including any monetary demand, other than the salary payable to the Employee by Teva and other benefits to which Employee is entitled, and the Employee will not be entitled to any moral rights (if any), royalties and/or any payment whatsoever, in consideration for and/or in connection with the Information Created by the Employee and/or its commercial use and/or other use or its transfer an...
INTELLECTUAL PROPERTY AND PATENTS. 8.1 All data, results and other information and reports generated in the performance of any Study (the “Study Results”) will be the property of COMPANY.
8.2 Subject to Section 13, COMPANY agrees to provide ▇▇▇▇▇ with [***], the “Study Reports”). [***]
8.3 All rights to all inventions and discoveries made or conceived in the course of any Study under a CSA Supplement [***] (each such invention or discovery, a “Combination Invention”) will belong jointly to ROCHE and COMPANY. If both Parties desire to file a patent application in respect of any Combination Invention, [***]. The preparation, filing and prosecution of such patent shall be discussed in good faith between the Parties. [***]. [***] use and have used, exploit and have exploited, grant licenses to, and assign its interest in, Combination Inventions and patents and patent applications claiming Combination Inventions (collectively “Combination Patents”) [***]. For clarity, (i) except for the right to use the Roche Compound solely for the purposes of conducting the Study in accordance with the terms of this Agreement, nothing in this Agreement will be deemed to create [***] and (ii) nothing in this Agreement will be deemed to create [***]. If [***] does not wish to initiate the, or wishes to discontinue the, prosecution or maintenance of a Combination Patent, [***]. In such event, [***].
8.4 All rights to inventions and discoveries made or conceived in the course of any Study under a CSA Supplement relating [***] (“Roche Inventions”); and ROCHE and its Affiliates shall be entitled to file in their own name relevant patent applications and to own resultant patent rights for such Roche Inventions[***].
8.5 All rights to [***] will be, as between the Parties, the exclusive property of COMPANY (“Company Inventions”); and COMPANY and its Affiliates shall be entitled to file in its own name relevant patent applications and to own resultant patent rights for such Company Inventions[***].
8.6 ROCHE acknowledges all rights of issued patents or pending patent applications of COMPANY from previous research and development[***].
8.7 COMPANY acknowledges all rights of issued patents or pending patent applications of ROCHE from previous research and development[***].
8.8 Notwithstanding anything else in this Agreement to the contrary, neither Party grants any license or any other rights to the other with respect to issued patents or pending patent applications or other intellectual property from research and develo...
INTELLECTUAL PROPERTY AND PATENTS. 9.1 Inventorship shall be determined according to United States Patent law.
9.2 All right and title to EMORY Intellectual Property shall belong to EMORY and shall not be subject to the terms and conditions of this Agreement. No rights in EMORY Intellectual Property are provided to CBT under any patents, patent applications, trade secrets or other proprietary rights of EMORY.
9.3 All right and title to CBT Intellectual Property shall belong to CBT and shall not be subject to the terms and conditions of this Agreement. No rights in CBT Intellectual Property are provided to EMORY under any patents, patent applications, trade secrets or other proprietary rights of CBT.
9.4 All right and title to EMORY Project Intellectual Property shall belong to EMORY and shall be Licensed Patents or Licensed Technology, and shall be subject to the rights and obligations and terms and conditions of the License Agreement.
9.5 All right and title to Joint Project Intellectual Property shall belong jointly to EMORY and to CBT and shall be Licensed Patents or Licensed Technology, and shall be subject to the terms and conditions of the License Agreement.
9.6 All right and title to Other EMORY Project Intellectual Property shall belong to EMORY and shall be subject to the terms and conditions of this Agreement.
9.7 All right and title to Other Joint Project Intellectual Property shall belong jointly to EMORY and to CBT and shall be subject to the rights and obligations and terms and conditions of this Agreement.
9.8 Within sixty (60) days of receiving a disclosure of EMORY Project Intellectual Property from the Principal Investigator and/or Investigators, EMORY shall fully disclose such EMORY Project Intellectual Property to CBT. CBT agrees to hold all such EMORY disclosures in confidence until a patent application(s) is filed to protect any invention(s) encompassed within the EMORY Project Intellectual Property, as provided for herein. Within sixty (60) days of receiving such disclosure from EMORY, CBT shall notify EMORY in writing if it wants EMORY to pursue patent protection for the EMORY Project Intellectual Property. Pursuant to Paragraph 7.1.1 of the License Agreement. EMORY shall be primarily responsible for all patent prosecution activities pertaining to the EMORY Project Intellectual Property. Pursuant to Paragraph 7.1.2 of the License Agreement, CBT shall bear all out-of-pocket costs in connection with such preparation, filing, prosecution, and maintenance of U.S. and for...
INTELLECTUAL PROPERTY AND PATENTS. Objective Objective 2: Rationalisation of the regional structures that operate in the promotion of research, technology transfer and the development of innovation Strand of activity 2.1: Definition and implementation, in collaboration with the Friuli Venezia Giulia Autonomous Region and the MUR, of an organisational model of Innovation Enablers Description of the intervention Development of a regional Patent and Competitive Intelligence hub through strengthening of collaborations between the Area Science Park PatLib Centre and SiS Partners for research, analysis and strategic management of technical and scientific information and patents to support technological-transfer activity, with particular focus on protection, management and promotion of Intellectual Property. More specifically, the intention is to establish channels and methods of interaction making it possible to support System Partners, both structurally and on demand, with the performance of studies and analyses aimed at identifying the applications potential of the results of research, with purposes all along the chain of processes for technological transfer, from protection of new discoveries to their commercialisation. Implementing bodies Area Science Park Starting date 2021 Planned duration Multi-year Planned expenditure SiS FVG 2021/2022/2023 Funds (partially covering operating costs, personnel and database, of the Area Science Park PatLib Centre) Output indicator • Development of an organisational model enabling systematization at the regional level of expertise and resources dedicated to promoting research • Identification of applications and industrial potential of results of research through studies and analyses into the relevant technological and patent scenario • Support for definition of strategies to protect Intellectual Property in terms of the results of research and evaluation of possibilities for extension, maintenance and continuation of industrial property rights • Identification of directions for development of innovations also through selection of potential industrial partners to involve in utilisation and commercialisation of the results of research. Result indicator The first year of the programme (December 2021–April 2022) was dedicated to planning of the system supporting activities for protection, management and promotion of Intellectual Property performed by SiS FVG Partners • Number of agreements with SiS FVG Partners (at least 4 in the first year) • Number of awarene...